Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Kala PharmaceuticalsBioXcel TherapeuticsMersana TherapeuticsIDEAYA BiosciencesHarrow Health
SymbolNASDAQ:KALANASDAQ:BTAINASDAQ:MRSNNASDAQ:IDYANASDAQ:HROW
Price Information
Current Price$4.41$10.54$1.90$9.79$5.94
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$20.6667$23.00$14.00$19.75$15.00
% Upside from Price Target368.63% upside118.22% upside636.84% upside101.74% upside152.53% upside
Trade Information
Market Cap$137.73 million$164.38 million$90.84 million$190.70 million$148.76 million
Beta2.153.051.51N/A0.15
Average Volume242,23860,232220,84739,433276,963
Sales & Book Value
Annual RevenueN/AN/A$10.59 millionN/A$41.37 million
Price / SalesN/AN/A8.58N/A3.61
CashflowN/AN/AN/AN/A$0.7030 per share
Price / CashN/AN/AN/AN/A8.45
Book Value$3.11 per share$2.49 per share$0.38 per shareN/A$1.06 per share
Price / BookN/AN/A5.00N/A5.60
Profitability
Net Income$-66,740,000.00$-19,270,000.00$-64,260,000.00N/A$14.63 million
EPS($2.48)($1.32)($2.79)N/A$0.61
Trailing P/E RatioN/AN/AN/A0.009.74
Forward P/E RatioN/AN/AN/AN/A18.00
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-77.78%N/A51.32%
Return on Equity (ROE)-117.68%-77.72%-51.13%N/A50.32%
Return on Assets (ROA)-52.43%-66.59%-30.04%N/A24.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.16%0.04%0.06%0.05%0.56%
Current Ratio7.50%3.93%5.50%18.94%3.87%
Quick Ratio7.04%3.93%5.50%18.95%3.60%
Ownership Information
Institutional Ownership Percentage68.63%19.05%83.57%25.12%34.37%
Insider Ownership Percentage30.77%64.80%29.20%N/A12.43%
Miscellaneous
Employees130188656N/A
Shares Outstanding34.01 million15.73 million47.81 million19.48 million25.17 million
Next Earnings Date11/14/2019 (Estimated)11/8/2019 (Estimated)11/12/2019 (Estimated)11/11/2019 (Estimated)11/12/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Kala PharmaceuticalsBioXcel TherapeuticsMersana TherapeuticsIDEAYA BiosciencesHarrow Health

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel